The PD-L1 expression was associated with unfavorable clinical and prognostic characteristics, such as a lower degree of differentiation 94, high proliferative index 79, advanced stage 80, larger tumor size 81 and younger age 82. This evidence concerns the gene CD274 and neoplasm.